Good Health Can’t Wait.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Good</strong> <strong>Health</strong> <strong>Can’t</strong> <strong>Wait</strong>.<br />
Dr. Reddy’s Laboratories Limited<br />
NOTES TO FINANCIAL STATEMENTS<br />
(All amounts in Indian Rupees millions, except share data and where otherwise stated)<br />
2.14: SHORT TERM LOANS AND ADVANCES<br />
PARTICULARS<br />
AS AT<br />
31 MARCH 2015<br />
AS AT<br />
31 MARCH 2014<br />
Unsecured<br />
Considered good<br />
Balances with statutory / government authorities 7,150 6,960<br />
Prepaid expenses 311 269<br />
Other advances 1,196 1,058<br />
Considered doubtful<br />
Other advances recoverable in cash or in kind or for value to be received 51 37<br />
8,708 8,324<br />
Less: Provision for doubtful loans and advances (51) (37)<br />
8,657 8,287<br />
2.15: OTHER ASSETS<br />
PARTICULARS<br />
AS AT<br />
31 MARCH 2015<br />
AS AT<br />
31 MARCH 2014<br />
A) Non current assets<br />
In term deposit accounts (remaining maturity more than 12 months) 11 -<br />
11 -<br />
B) Current assets<br />
Considered good<br />
Claims receivable 326 161<br />
Interest accrued but not due on term deposits 92 175<br />
Derivative financial asset 388 580<br />
Receivables from subsidiary companies including step down subsidiaries:<br />
Reddy Antilles N.V., Netherlands 16 19<br />
Dr. Reddy’s Bio-sciences Limited, India 69 70<br />
Dr. Reddy’s Laboratories SA, Switzerland 29 332<br />
Betapharm Arzneimittel GmbH, Germany - 534<br />
Others 21 18<br />
Other current assets 49 51<br />
990 1,940<br />
2.16: OTHER OPERATING REVENUE<br />
PARTICULARS<br />
FOR THE YEAR ENDED<br />
31 MARCH 2015<br />
FOR THE YEAR ENDED<br />
31 MARCH 2014<br />
Sale of spent chemicals 521 481<br />
Scrap sales 270 135<br />
Miscellaneous income 44 196<br />
835 812<br />
134
Change language